TODAY’S RESEARCH FOR TOMORROW'S HEALTH

SYREON

RESEARCH

INSTITUTE

Syreon Research Romania (SRR) is an independent research oriented company, part of the Syreon network.

The international experience of the Syreon Research Institute’s co-founders, Dr. Kaló Zoltán and Syreon Corporation’s founder Dr. Paul Keown, was combined with the local experience in health economics and health service management of Dr. Lorenzovici László, supported by a team of multidisciplinary specialists with extensive knowledge in the healthcare sector in Romania.

For more information about Syreon Group please visit www.syreon.eu and www.syreon.com

Our company has been providing expert services since 2013 and carries out and coordinates a wide range of analyses in the field of health economics, epidemiology and health policy. Syreon Research Romania operates in two locations, headquartered in Tîrgu Mureș, with an office in Bucharest, giving us the opportunity to be closer to you!

Who we are

NEWS

October 8, 2022

Conferinta Nationala de Farmacoeconomie si Management Sanitar 2022, EDIȚIA A IX-A

Health Technology Assessment workshop: from the basics to the impact of new health technologies on the payment system Speaker: Zoltán KALÓ, Professor of health economics, Semmelweis University of Budapest, Hungary / Syreon Research Institute

October 16, 2021

Conferinta Nationala de Farmacoeconomie si Management Sanitar 2021, EDIȚIA A VIII-A

National Conference of Pharmacoeconomics and Health Management, 8th edition

January 20, 2021

A apărut Newsletterul proiectelor ERAPerMed care au fost desemnate câștigătoare în anul 2020

CLL-CLUE: Tailoring the targeted treatment of chronic lymphocytic leukemia

November 9, 2020

ERA PerMed grant awarded to European consortium led by Sigrid S. Skånland

CLL-CLUE: Tailoring the targeted treatment of chronic lymphocytic leukemia

MORE NEWS
“

Thank you for the terrific draft epidemiology report! I have been reading the literature for quite some time now, and I found the draft report illuminating and informative. It reads well and provides useful epi data, summarized in a clear and succinct manner.

Associate Director of an International Company
“

A big thank you for giving the MEA seminar in our country. The content you covered was very much on point, relevant for our market, and clearly resonated with the audience.

Head of Oncology Policy and Market Access of Multinational Pharmaceutical Company
“

I wish to thank the Syreon Team for the continuous support they have been providing us across several years to ensure the success of the European launch of our product.

Strategic Marketing and Licensing Division of Global Pharmaceutical Company
“

This is a fabulous paper, beautifully constructed, and a wonderfully invaluable guide for future researchers. A little masterpiece of concision. Great job.

Professor Emeritus, US Medical University
“

Thank YOU very much for your excellent support.

Global International Health Organization
“

My deepest thank you to you and Syreon for delivering this ad hoc work on time and so well done. You don't know how much I appreciate having you as a resource to rely on.

Vice President of Multinational Pharmaceutical Company
“

Wow, my compliments to the entire team; your findings, once again, are incredible. Thank you!

Head of Market Access Division at a Pharmaceutical Company